Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL193840 | 0.97 | — | — | |
| SCHEMBL9748138 | 0.97 | — | — | |
| SCHEMBL9748670 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL9748547 | 0.93 | — | — | |
| Water SCHEMBL22462356 | 0.93 | MAPT (0.40) | — | |
| Fluoride Ion SCHEMBL1502834 | 0.93 | — | — | |
| Water SCHEMBL11879378 | 0.93 | MAPT (0.40) | — | |
| Hydrochloric Acid SCHEMBL194776 | 0.93 | — | — | |
| Water SCHEMBL341614 | 0.93 | — | — | |
| Bromide SCHEMBL1502778 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017187245-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF APIXABAN | OPTIMUS DRUGS (P) LIMITED (IN) | 2017-11-02 | — | — | WO | claimed |
| US-20170313695-A1 | PROCESS FOR THE PREPARATION OF APIXABAN | OPTIMUS DRUGS PRIVATE LIMITED (IN) | 2017-11-02 | — | — | US | claimed |
| US-6773822-B2 | ANTIFUNGAL AGENT MAY BE PRESENT IN THE GYPSUM CORE AND/OR ON ONE OR BOTH OF THE PAPER FACINGS, AND MAY BE ENCAPSULATED IN A MATERIAL THAT RELEASES THE ANTIFUNGAL AGENT OVER TIME AND/OR UPON EXPOSURE TO MOISTURE. | TEMPLE-INLAND FOREST PRODUCTS CORPORATION | 2004-08-10 | — | — | US | claimed |
| US-20240084067-A1 | NOVEL CURABLE COMPOSITION CONTAINING CYCLIC MONOMER | TOKUYAMA CORPORATION (JP) | 2024-03-14 | — | — | US | disclosed |
| EP-4286435-A1 | NOVEL CURABLE COMPOSITION CONTAINING CYCLIC MONOMER | Tokuyama Corporation (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-114728255-A | Microspheres containing ionic groups and method for producing same | 株式会社德山 | 2022-07-08 | — | — | CN | disclosed |
| EP-3318543-B1 | METHOD FOR PRODUCING ORGANIC COMPOUND | M TECHNIQUE CO LTD (JP) | 2021-11-17 | — | — | EP | disclosed |
| CN-110477861-A | To ensure the sweat sensing in a manner of time sequencing | UNIV CINCINNATI | 2019-11-22 | — | — | CN | disclosed |
| CN-105916433-B | Sweat sensing in a chronological manner | 辛辛那提大学 | 2019-08-30 | — | — | CN | disclosed |
| US-10287232-B2 | Method for producing an organic compound in a rotating forced thin-film microreactor | M. TECHNIQUE CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| US-10077263-B2 | Process for the preparation of Apixaban | OPTIMUS DRUGS PRIVATE LIMITED (IN) | 2018-09-18 | — | — | US | disclosed |
| US-20040087802-A1 | Process for preparing glycidylphthalimide | OSAKA SODA CO., LTD. (JP) | 2004-05-06 | — | — | US | disclosed |
| EP-1403267-A1 | Process for preparing glycidylphthalimide | DAISO CO., LTD. (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-6680127-B2 | COMPRISING AN ANTIFUNGAL AGENT AND A RETENTION AID, SUCH AS A SURFACTANT, IN ONE OR MORE PAPER FACINGS. | TEMPLE-INLAND FOREST PRODUCTS, CORPORATION | 2004-01-20 | — | — | US | disclosed |
| US-20030035981-A1 | Antifungal gypsum board | TIN INC. D/B/A TEMPLE-INLAND | 2003-02-20 | — | — | US | disclosed |
| US-20030031898-A1 | Antifungal gypsum board | TIN INC. D/B/A TEMPLE-INLAND | 2003-02-13 | — | — | US | disclosed |
| EP-0435068-B1 | Process for producing optically active atenolol and intermediate thereof | DAISO CO LTD (JP) | 1995-03-29 | — | — | EP | disclosed |
| US-5223646-A | Process for producing optically active atenolol and intermediate thereof | DAISO COMPANY, LTD. (JP) | 1993-06-29 | — | — | US | disclosed |
| US-5130482-A | PROCESS FOR PRODUCING OPTICALLY ACTIVE ATENOLOL AND INTERMEDIATE THEREOF | DAISO COMPANY, LTD. (JP) | 1992-07-14 | — | — | US | disclosed |
| EP-0435068-A2 | Process for producing optically active atenolol and intermediate thereof | DAISO CO., LTD. (JP) | 1991-07-03 | — | — | EP | disclosed |